20 February 2002:
Research Bioethics & Public Health
1900 Welcome drinks reception
Forum registration (Please note - Whilst registration will be possible on the morning of Thursday 21 February, delegates attending the welcome reception are encouraged to register during the evening of the 20th)
Venue: The Villa Room (2nd Floor)
21 February 2002: Research Bioethics & Public Health
The Forum will take place in the Stellenbosch and Constantia rooms located on the 2nd Floor. Delegates will be informed of breakout group membership and locations during registration.
8:00 Forum registration (for any delegates who were unable to register during the welcome reception)
8:30 Welcome: Dr Malegapuru Makgoba (*)(MRC South Africa) and Mr Nick Winterton (MRC UK)
8:40 Keynote speech: Professor Sir Kenneth Calman (University of Durham, UK)
Theme 1: Do current guidelines promote or constrain post-trial access to drugs, devices and vaccines?
Session co-chaired by Dr Malegapuru Makgoba (*)(MRC South Africa) and Mr Nick Winterton (MRC UK)
9:10 Plenary introduction: Dr Churchill Lukwiya Onen (Princess Marina Hospital, Gaborone, Botswana)
9:40 Presentation of two relevant case studies: Professor Ruth Macklin (Albert Einstein College of Medicine, USA)
- Case study 1: access to treatment following clinical trials: the case of a pneumococcal -conjugate vaccine trial in The Gambia
- Case study 2: what are researchers' and institutions' responsibilities to the study community?
9:50 Break
10:10 Discussion of case studies in breakout groups
12:10 Report back from breakout groups in plenary session
13:00 Lunch
14:00 Keynote speech: Mr Doug Wassenaar (University of Natal, South Africa)
Theme 2: Creating a national framework for ethical research: what's needed and how to go about it
Session co-chaired by Dr Godwin Ndossi (Tanzania Food & Nutrition Centre, Tanzania) and Professor Keith McAdam (MRC Laboratories, The Gambia)
14:30 Plenary introduction: Professor Godfrey Tangwa (University of Yaoundé, Cameroon)
15:00 Presentation of two relevant case studies: Professor Zulfiqar Ahmed Bhutta (Aga Khan University, Pakistan)
- Case study 3: obligations to third parties in the face of possible harm
- Case study 4: is community consent authentic and legitimate?
15:10 Break
15:30 Discussion of case studies in breakout groups
17:30 Report back from breakout groups in plenary session
18:20 End of session
20:00 Gala dinner in the hotel
22 February 2002:
8:40 Keynote speech: Dr Peter Singer (University of Toronto, Canada)
Theme 3: Best current methods: balancing standards of care with appropriate trial design
Session co-chaired by Dr Dafna Feinholz-Klip (Instituto Nacional de Perinatalogia, Mexico)
9:10 Plenary introduction: Dr Maarten Schim van der Loeff (MRC Laboratories, The Gambia)
9:40 Presentation of two relevant case studies: Dr James Lavery (Fogarty International Centre, USA)
- Case study 5: evaluating the use of traditional medicines
- Case study 6: the wider implications of preventing mother-to-child transmission of HIV, and subsequent management of women and children, in rural Uganda
9:50 Break
10:10 Discussion of case studies in breakout groups
12:10 Report back from breakout groups in plenary session
13:00 Lunch
Afternoon - Arrangements to be confirmed
Evening - Informal dinner (Arrangements to be advised)
23 February 2002:
9:00 Summing up of proceedings: Dr Malegapuru Makgoba (*)(MRC South Africa) and Mr Nick Winterton (MRC UK)
9:30 Business meeting - purpose and future of Global Forum
11:30 Preview of next meeting
11:45 End of formal proceedings followed by LUNCH at the hotel
